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e have previously reported that 1-benzyl-
2-acetamido-2-deoxy-
 
 
 
-
 
D
 
-galactopyranoside
(GalNAc
 
 
 
-
 
O
 
-bn), an inhibitor of glycosyla-
tion, perturbed apical biosynthetic trafﬁcking in polarized
HT-29 cells suggesting an involvement of a lectin-based
mechanism. Here, we have identiﬁed galectin-4 as one of
the major components of detergent-resistant membranes
(DRMs) isolated from HT-29 5M12 cells. Galectin-4 was
also found in post-Golgi carrier vesicles. The functional
role of galectin-4 in polarized trafﬁcking in HT-29 5M12
cells was studied by using a retrovirus-mediated RNA
W
 
interference. In galectin-4–depleted HT-29 5M12 cells
apical membrane markers accumulated intracellularly. In
contrast, basolateral membrane markers were not af-
fected. Moreover, galectin-4 depletion altered the DRM
association characteristics of apical proteins. Sulfatides
with long chain-hydroxylated fatty acids, which were also
enriched in DRMs, were identiﬁed as high-afﬁnity ligands
for galectin-4. Together, our data propose that interaction
between galectin-4 and sulfatides plays a functional role
in the clustering of lipid rafts for apical delivery.
 
Introduction
 
Epithelial cells contain two distinct surfaces with different
composition and function. This polarity implies a strict regula-
tion of the targeting of components to each surface of the cell
(Mostov et al., 2000). Sorting of proteins toward the basolateral
membrane is encoded by tyrosine or di-leucine–based motifs,
localized in the cytoplasmic domain (Matter and Mellman,
1994). These sorting motifs are recognized by adaptor com-
plexes (APs; Nakatsu and Ohno, 2003). An AP complex (AP-
1B) specifically expressed in epithelial cells is involved in sort-
ing to the basolateral membrane (Folsch et al., 1999).
The apical delivery has been proposed to involve the re-
cruitment of apical glycoproteins into lipid rafts, which would
then bud from the TGN to form apical carrier vesicles (Simons
and Ikonen, 1997; Schuck and Simons, 2004). Rafts are mem-
brane microdomains enriched in sphingolipids and cholesterol.
Raft association plays a role in sorting to the apical surface
(Brown and Rose, 1992; Lipardi et al., 2000; Alfalah et al.,
2002). However, this association is not sufficient for apical de-
livery (Benting et al., 1999). At present, the signals and mecha-
nisms by which proteins are specifically targeted to the apical
surface are not fully understood. Involvement of N- and/or
O-linked glycans was documented by studies using mutation,
deletion or addition of glycosylation sites, or using drugs af-
fecting the processing of oligosaccharide chains (Scheiffele et
al., 1995; Yeaman et al., 1997; Gut et al., 1998; Huet et al.,
1998; Monlauzeur et al., 1998; Alfalah et al., 1999, 2002; Bent-
ing et al., 1999; Jacob et al., 2000). VIP36, a lectin identified as a
component of isolated carrier vesicles, has been implicated in
sorting of proteins for apical delivery (Fiedler and Simons, 1996).
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However, subsequent studies reported that VIP36 cycles in the
early secretory pathway without moving beyond the Golgi
complex thereby challenging the role of this lectin in apical
sorting (Füllekrug et al., 1999; Hara-Kuge et al., 2004).
A role for glycosylation in apical transport was further
supported by our observations that biosynthetic transport of
apical but not basolateral glycoproteins was perturbed in 1-ben-
zyl-2-acetamido-2-deoxy-
 
 
 
-
 
D
 
-galactopyranoside (GalNAc
 
 
 
-
 
O
 
-
bn)–treated HT-29 cells (Huet et al., 1998; Gouyer et al., 2001).
GalNAc
 
 
 
-
 
O
 
-bn is thought to function as a competitive inhibitor
of the elongation of 
 
N
 
-acetylgalactosamine, the first sugar resi-
due in O-linked glycans. However, not only 
 
O
 
-glycosylated
glycoproteins but also 
 
N
 
-glycosylated proteins as well as pro-
teins implicated in regulation of apical traffic accumulated in-
tracellularly in GalNAc
 
 
 
-
 
O
 
-bn–treated HT-29 cells (Delacour
et al., 2003). GalNAc
 
 
 
-
 
O
 
-bn is extensively metabolized in
HT-29 cells and could, thus, also interfere with other glycosyla-
tion processes than the 
 
O
 
-glycosylation (Delannoy et al., 1996;
Zanetta et al., 2000).
Based on these results, we have now investigated whether
a lipid raft-based lectin-dependent mechanism of apical target-
ing could be operating in epithelial HT-29 cells.
 
Results
 
To identify proteins possibly associated with lipid rafts in
HT-29 5M12 we used 2-dimensional (2-D) electrophoresis
and matrix-assisted laser desorption/ionization–time of flight
(MALDI-TOF) mass spectrometry analysis of detergent-resis-
tant membrane fractions (DRMs).
 
Galectin-4 is a major component of 
DRMs in HT-29 5M12 cells
 
The 2-D gel electrophoresis pattern of DRMs is shown in Fig. 1,
and the identity of corresponding proteins in Table I. Besides
flotillin-1, an ubiquitous marker of DRMs, the proteins identi-
fied could be divided into eight groups: (1) G proteins (G(i)
 
 
 
1,2,3, G11, GTPase-activating protein for Rab6); (2) proteins
of SNARE machinery (NSF, SNAP23); (3) proteins of vesicu-
lar structures (Rab22a, annexin II); (4) chaperone proteins
(heat-shock protein 90 (hsp90), BiP, endoplasmin, hsp73); (5)
ionic pumps (V-ATPase, voltage-dependent anion channel 2);
(6) membrane cytoskeleton and intermediate filament-associ-
ated proteins (
 
 
 
II-spectrin, 
 
 
 
4-actinin, myosin light chain,
periplakin, mitofilin, cytokeratins 8, 18, 19, and 20); (7) api-
cal membrane glycoproteins dipeptidylpeptidase-IV (DPP-IV),
carcinoembryonic antigen (CEA), nonspecific cross-reacting
antigen, 5
 
 
 
-nucleotidase, CD59); and (8) a member of the ga-
lectin family of lectins, galectin-4. Proteins of the three latter
groups were the major proteins of the DRMs.
 
GalNAc
 
 
 
-
 
O
 
-bn decreases the amount of 
galectin-4 associated with DRMs
 
Prompted by the hypothesis of a role for glycans in apical
transport, we analyzed whether galectin-4 was present in
DRMs in GalNAc
 
 
 
-
 
O
 
-bn–treated cells. The 2-D gel electro-
phoresis protein pattern of DRMs of GalNAc
 
 
 
-
 
O
 
-bn–treated
cells was similar to that of control cells (Fig. 1). Marked quali-
tative and/or quantitative changes were observed for a number
of proteins. Interestingly, the levels of galectin-4 in DRMs
were strongly decreased in GalNAc
 
 
 
-
 
O
 
-bn–treated cells, point-
ing to an effect of GalNAc
 
 
 
-
 
O
 
-bn on the interaction of galec-
tin-4 with raft-associated compounds.
 
GalNAc
 
 
 
-
 
O
 
-bn modifies the cellular 
distribution of galectin-4
 
The distribution of galectin-4 in control and in GalNAc
 
 
 
-
 
O
 
-
bn–treated cells was studied by analyzing the culture medium,
the cytosolic and the total membrane fractions from saponin-
permeabilized cells for the presence of galectin-4 (Fig. 2 A). In
control cells, galectin-4 was found in the membrane fraction,
Figure 1. Analysis of proteins contained in DRMs of control and Gal-
NAc -O-bn–treated HT-29 cells. 2-D patterns were obtained using 300
 g of DRM proteins isolated from control and GalNAc -O-bn–treated
(14 d) cells. Each protein spot was numbered and submitted to mass
spectrometry analysis in MALDI-TOF mode. Spot number 32 was identified
as galectin-4 (arrows). 
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whereas in GalNAc
 
 
 
-
 
O
 
-bn–treated cells, galectin-4 was found
in the soluble cytosolic fraction. Neither the control cells nor
the GalNAc
 
 
 
-
 
O
 
-bn–treated cells secreted detectable levels of
galectin-4 to the culture medium.
Confocal microscopy on permeabilized cells showed that
galectin-4 was distributed throughout the cytoplasm, but mostly
in the subapical region (Fig. 2 B). Furthermore, immunostain-
ing on nonpermeabilized cells revealed the presence of galec-
tin-4 at the extracellular surface of the apical membrane. This
extracellular galectin-4 staining disappeared if cells were treated
with trypsin from the outside (unpublished data). In permeabi-
lized GalNAc
 
 
 
-
 
O
 
-bn–treated cells accumulation of galectin-4
in the subapical region was no longer observed (Fig. 2 B).
Moreover, a clear decrease in the extracellular fraction of ga-
lectin-4 at the apical membrane was observed in GalNAc
 
 
 
-
 
O
 
-bn–treated, nonpermeabilized cells (Fig. 2 B).
 
Galectin-4 is associated with DRMs in 
post-Golgi carrier vesicle preparations
 
We then proceeded to analyze whether galectin-4 was present
in membrane vesicles released from perforated HT-29 cells
(Wandinger-Ness et al., 1990). Immunoelectron microscopy
demonstrated that galectin-4 was in carrier vesicles containing
DPP-IV (Fig. 3 A).
To determine whether galectin-4 was localized on the lu-
menal or cytoplasmic side of these vesicles, we subjected the
vesicle preparations to trypsin. Galectin-4 was not sensitive to
trypsin, suggesting that the lectin was localized on the lumenal
side of post-Golgi vesicles (Fig. 3 B). Galectin-4 in these
preparations became susceptible to trypsin upon addition of
detergent (Fig. 3 B).
Galectin-4 has been previously described as an intestinal
brush border protein with potential functions as a raft stabi-
lizer/organizer characterized by insolubility in Triton X-100 at
37
 
 
 
C (“super-rafts”; Danielsen and van Deurs, 1997; Braccia
et al., 2003). We therefore examined the DRM association of
galectin-4 in isolated post-Golgi vesicles of HT-29 5M12 cells
using the two-step procedure described by Braccia et al.
(2003). Vesicle preparations were treated by 1% Triton X-100
at 4
 
 
 
C, fractionated into supernatant (S) and pellet; the pellet
was resuspended into Triton X-100, incubated at 37
 
 
 
C and
then further fractionated into supernatant (P1) and pellet (P2).
Galectin-4 was only present in P2, i.e., the detergent-insoluble
fraction at 37
 
 
 
C (Fig. 3 C). DPP-IV was similarly detected
only in the Triton X-100–insoluble fraction at 37
 
 
 
C. Annexin
XIIIb and XIIIa were partially Triton X-100 soluble at 4
 
 
 
C but
their DRM fraction remained insoluble at 37
 
 
 
C (particularly
for annexin XIIIb).
 
GalNAc
 
 
 
-
 
O
 
-bn treatment decreases the 
amount of glycosphingolipids in DRMs of 
HT-29 5M12 cells
 
We then investigated the effect of GalNAc
 
 
 
-
 
O
 
-bn on the lipid
composition of the DRMs using a quantitative analysis by high
performance thin layer chromatography (HPTLC) and gas
chromatography mass spectrometry (GC-MS) in reference to
the total membrane fraction. Results in control cells demon-
strated enrichment of glycosphingolipids (from 12.16% in total
membrane preparation to 34.90% in total DRM preparation)
and cholesterol (from 22.78 to 35.13% in DRMs). Sphingomy-
elin was barely detectable. Among the glycosphingolipids, ga-
lactosyl-ceramides were the major class (51.18%), followed by
Figure 2. GalNAc -O-bn decreases the apical localization of galectin-4. (A) Western blot of culture media, cytosol and membrane fractions of control
and GalNAc -O-bn–treated (14 d) cells after permeabilization with saponin, using anti–galectin-4 antibody. (B) Confocal microscopy with an anti–galectin-4
antibody on permeabilized or unpermeabilized control and GalNAc -O-bn–treated (14 d) cells. Apical and xz sections are shown. Bars, 22  m. 
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sulfatides (33.05%), GM3 (12.98%), and GM1 (2.79%; Table II).
Fatty-acid methyl esters (FAMEs) analysis revealed that
DRMs were enriched in hydroxylated fatty acids (all hydrox-
ylated in position 2 with a predominance of the C24:0 chain;
11.36% vs. 0.32% in total membranes).
When DRMs were prepared from cells treated with Gal-
NAc
 
 
 
-
 
O
 
-bn the amount of cholesterol increased by twofold
(54.56% vs. 35.13% in control cells), whereas the amount of
glycosphingolipids was decreased by twofold (16.50% vs.
34.90% in control cells; Table II). FAMEs analysis showed a
decrease in hydroxylated C24:0 (7.58% vs. 11.36% in control
cells), with a simultaneous increase in mono-unsaturated
FAMEs (C16:1 and C18:1). These changes after GalNAc
 
 
 
-
 
O
 
-bn treatment prompted us to look for galactosylated glyco-
sphingolipids as ligands for galectin-4.
 
Identification of glycosphingolipids as 
carbohydrate ligands of galectin-4
 
Galectin-4 immunoprecipitates were analyzed by HPTLC (Fig.
4 A), GC-MS, and MALDI-TOF mass spectrometry. In control
 
Table I. 
 
Identification of common protein components in DRMs from control and GalNAc
 
 -O-benzyl–treated HT-29 5M12 cells
Protein parameters MALDI-TOF MS
Spot no. Identity Accession no. MW (kD) pI Matched peptides Sequence coverage
1 Spectrin, non-erythroid   chain,  -II spectrin, fodrin   chain Q13813 285,85 5,2 45 22%
2 Periplakin O60437 204,65 5,44 19 15%
3 Clathrin heavy chain Q00610 193,37 5,5 9 8%
4 Carcinoembryonic antigen (CEA) P06731 76,79 5,43 3 7%
5 Integrin alpha chain, alpha 6 P23229 126,62 6,39 9 13%
6 Dipeptidylpeptidase IV (cd26, adenosine desaminase
complexing protein 2)
P27487 88,27 5,67 16 23%
7  -Actinin 4 (F-actin cross linking protein) O43707 104,85 5,27 28 33%
8 Vesicular-fusion protein NSF (N-ethylmaleimide–sensitive
fusion protein) (NEM-sensitive protein)
P46459 82,65 6,38 5 8%
9 Endoplasmin precursor (94-kD glucose-regulated protein) (GRP94) P14625 92,47 4,76 10 18%
10 Heat shock protein 90-kD (hsp90) P07900 84,54 4,94 7 16%
11 Junction plakoglobin P14923 81,49 5,95 23 38%
12 Mitofilin Q16891 79,86 5,7 23 34%
13 BiP P11021 72,33 5,07 18 34%
14 Carcinoembryonic antigen-related cell adhesion molecule 6
precursor, normal cross-reacting antigen, nonspecific
cross-reacting antigen (NCA) CD66c 
P40199 37,24 5,56 3 8%
15 CD73 (5 -nucleotidase) P21589 63,36 6,58 7 18%
16 Heat shock cognate 71-kD protein (hsc71) (hsp73) P11142 70,89 5,37 14 27%
17 Vacuolar ATP synthase subunit B (V-ATPase B subunit) P15313 56,98 5,52 11 28%
18 Keratin 9, type I cytoskeletal P35527 61,98 5,14 17 46%
19 Keratin 8, type II cytoskeletal P05787 53,54 5,52 21 37%
20 Keratin 20, type I cytoskeletal P35900 48,48 5,52 11 31%
21 Keratin 18, type I cytoskeletal P05783 53,54 5,52 21 37%
22 Flotillin-1 O75955 47,33 7,04 8 26%
23 Keratin 19, type I cytoskeletal P08727 44,1 5,05 28 65%
24 Protein G11 P29992 42,12 5,51 4 16% 
25 Vacuolar ATP synthase subunit C (V-ATPase C subunit) P21283 43,94 7,02 37 22%
26 Vacuolar ATP synthase subunit D (V-ATPase D subunit) P12953 40,33 4,89 7 22%
27 Guanine nucleotide-binding protein  -I subunit (G(i)  2) P04899 41 5,3 5 20%
28 Guanine nucleotide-binding protein  -I subunit (G(i)  3) P08754 41,08 5,5 5 19%
29 Guanine nucleotide-binding protein  -I subunit (G(i)  1) P04898 40,91 5,7 6 21%
30 Guanine nucleotide-binding regulatory protein- -2 subunit,
transducin  -2 subunit (G 2)
P11016 37,33 5,6 14 49%
31 Annexin II (lipocortin II) (calpactin I heavy chain) P07355 38,47 7,56 13 35%
32 Galectin-4; lectin galactoside-binding soluble 4 P56470 35,94 9,21 9 39%
33 Voltage-dependent anion channel 2 (VDCA2) 32,09 7,7 6 35%
34 Ras-related protein Rab-22A Q9UL26 21,85 8,32 4 35%
35 Prohibitin P35232 29,84 5,6 6 30%
36 Synaptosomal-associated protein 23 (SNAP-23)
(vesicle-membrane fusion protein SNAP-23)
O00161 23,35 4,89 6 34%
37 Rab6 GTPase activating protein, GAPCenA Q9Y3P9 23,56 5,4 6 9%
38 CD59 (protectin) P13987 14,17 6,02 3 26%
39 Myosin light chain, non-muscle isoform P16475 17,08 4,6 10 54%
Spot proteins are numbered on 2-D gels in Fig. 1 A. The SWISS-PROT and TREMBL accession nos. are listed. Theorical molecular masse, isoeletric point, number of
matched peptides, and sequence coverage obtained along the searches in databases are presented. Spectra were acquired by MALDI-TOF mass spectrometry.
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cells, galactosyl-ceramides and sulfatides were identified as
major constituents. Gangliosides were not detected. The fatty
acid composition showed a high content of 2-hydroxylated
FAMEs with chain length of 18 or 22 to 26 carbon atoms
( 50%; 24:0).
When similar experiments were performed on cells
treated with GalNAc -O-bn for 12 d, the quantity of material
recovered was extremely low ( 1% of the control cells) and
not detectable by HPTLC, indicating a dramatic inhibition in
the formation of glycosphingolipid–galectin-4 complexes (Fig.
4 A). A short time exposure to GalNAc -O-bn (18 h) was also
used and trace amounts of less polar sulfatides were recovered
( 10% of the control).
To gain further insight into possible glycosphingolip-
ids–galectin-4 interactions, we used human glycosphingolipid
preparations from sciatic nerve, for overlay experiments with
the recombinant NH2- or COOH-terminal domains of galectin-4.
Each of these domains contains one of the two carbohydrate
recognition domains (CRDs) in galectin-4. A strong binding of
both the NH2-terminal and COOH-terminal domain of galectin-4
was observed to the more polar fraction of sulfatides, i.e., those
substituted by 2-hydroxylated fatty acids (Fig. 4 B). In contrast,
Table II. Lipid analysis of total membranes and DRMs
Control cells
Sugars Total 
membranes
Total 
DRMs
FAMEs Total 
membranes
Total 
DRMs
Lipids Total 
membranes
Total DRMs
Fuc 0.19 1.2 C14:0 2.14% 4.87% Chol 22.78% 35.13%
Ins 0 1.08 C15:0 0.00% 1.51%
Gal 7.66 16.16 C16:1 19.92% 1.61% PL 65.06% 24.97%
Man 0 0.44 C16:0 18.08% 31.18% PE 11.12% 25.53%
GalNAc 1 1 C16:0oh2 0.87% 3.28% PI 0.25% 14.95%
GlcNAc 0 2.59 C18:1 45.05% 4.34% PS 0.25% 37.74%
NeuAc 0.59 2.05 C18 :0 12.50% 31.96% PC 88.39% 21.15%
Total 9.44 24.52 C22 :0 0.00% 1.98%
C22 :0oh2 0.79% 3.12% GSL 12.16% 34.90%
LCBs C23 :0oh2 0.32% 2.19% Gce 6.30% 51.18%
Spha 26.04% 14.02% C24 :1oh2 0.00% 1.62% LacC 8.24% ND
6ohSphe 32.23% 28.86% C24 :0oh2 0.32% 11.36% Sul 84.09% 33.05%
Sphe 23.13% 16.24% C25 :0oh2 0.01% 0.62% GM3 ND 12.98%
Phyt 18.60% 40.87% C26 :0oh2 0.00% 0.35% GM1 ND 2.79%
GD1a 0.39% ND
AAG FAM/LCB 9.487 1.472 GD1b ND ND
C16:0 48.99% 68.22% AAG :LCB 1.106 0.079 GT1b ND ND
C18:1 29.70% 4.34% Sugar/LCB 1.499 1.137
C18:0 21.31% 31.78% Gal+N/LCB 1.392 0.796 SM ND  5%
Treated cells
Fuc 0.32 1.42 C14:0 3.35% 3.42% Chol 22.57% 54.56%
Ins 3.19 1.72 C15:0 0.36% 0.97%
Gal 9.25 17.71 C16:1 21.60% 5.06% PL 64.86% 23.94%
Man 0 1.07 C16:0 18.81% 32.36% PE 8.07% 25.69%
GalNAc 0 1 C16:0oh2 1.07% 2.46% PI 2.80% 15.05%
GlcNAc 1 2.32 C18:1 40.28% 19.78% PS 2.80% 37.98%
NeuAc 0.73 2.24 C18 :0 12.13% 21.79% PC 83.33% 21.13%
Total 14.49 27.47 C22:0 1.44% 1.49%
C22 :0oh2 0.70% 2.22% GSL 2.57% 16.50%
LCBs C23 :0oh2 0.26% 1.13% Gce 6.98% 39.11%
Spha 37.22% 12.41% C24 :1oh2 0.00% 1.31% LacC ND ND
6ohSphe 24.65% 29.47% C24 :0oh2 0.00% 7.58% Sul 93.03% 38.8%
Sphe 24.45% 24.84% C25 :0oh2 0.00% 0.32% GM3 ND 22.09%
Phyt 13.68% 33.27% C26 :0oh2 0.00% 0.13% GM1 ND ND
GD1a ND ND
AAG FAM/LCB 9.087 2.425 GD1b ND ND
C16:0 0.00% 67.87% AAG :LCB 1.114 0.113 GT1b ND ND
C18:1 58.37% 19.78% Sugar/LCB 2.976 1.422
C18:0 41.63% 32.13% Gal+N/LCB 2.167 0.968 SM ND  5%
Monosaccharides and inositol (Ins), FAMEs, long-chains bases (LCBs), and alkyl-acyl-glycerols (AAGs) were determined in single GC/MS experiments as the HFB
derivatives of the constituents released using acid-catalyzed methanolysis. The relative molar proportion of cholesterol (Chol) and of phospholipids (PL) was determined
by scanning the iodine stain of HPTLC plates. The relative molar proportions of glycosphingolipids (GSL) was determined by scanning the orcinol-sulfuric acid staining
of HPTLC plates and the molar ratio of sialylated compounds relative to cerebrosides and sulfatides confirmed by GC/MS analysis. FAMEs hydroxylated in position
2 are termed as (Cn:0/1)oh2 where n = the no. of carbon atoms of the chain and 0/1 the no. of double bonds. PE, phosphatidylethanolamine; PI, phosphatidylinositol;
PS, phosphatidylserine; PC, phosphatidylcholine; GalCer, galactosyl-ceramides; LacCer, lactosyl-ceramides. ND, not detected; Phyt, phytosphingosine; SM,
sphingomyelin; Spha, sphinganine; 6ohSphe, 6-hydroxy-sphingosine; Sul, sulfatides. Results are expressed as molar ratio or percentage of molar ratio.JCB • VOLUME 169 • NUMBER 3 • 2005 496
the less polar sulfatides did not show any binding to the do-
mains of galectin-4. In addition, a weak binding to the more
polar galactosyl-ceramides was observed with the COOH-ter-
minal domain of galectin-4. The addition of galactose (0.3 M)
and lactose (0.1 M) during the incubation did not significantly
reduce the binding of the two galectin-4 domains to the gly-
cosphingolipids. No binding to gangliosides was observed
(unpublished data).
The human sciatic nerve galectin-4 ligands were further
characterized by GC-MS and MALDI-TOF mass spectrometry.
Results showed that these ligands corresponded to sulfatides
and galactosylceramides showing a similar composition as
those identified after co-immunoprecipitation from HT-29
5M12 cells with the anti–galectin-4 antibody. By NMR spec-
troscopy, we demonstrated that galectin-4 ligands were  -galac-
tosylceramides and 3-sulfated- -galactosylceramide both con-
taining 2-hydroxylated fatty acids (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200407073/DC1).
Sulfatides are found in DRMs, which are 
detergent insoluble at 37 C
To gain further insight into the role of these glycosphin-
golipid–galectin-4 complexes in detergent insolubility of raft
microdomains, DRMs were first isolated from a total mem-
brane preparation of control and GalNAc -O-bn–treated cells
using 1% Triton X-100 at 4 C. These DRMs, insoluble at 4 C,
were then incubated at 37 C and both the soluble and the in-
soluble material (DRMs being detergent insoluble at 37 C)
were examined by HPTLC (Fig. 5). The results showed the
presence of galactosylceramides in all DRM fractions of con-
trol and GalNAc -O-bn–treated cells, whereas sulfatides were
Figure 3. Galectin-4 is associated with DRMs of post-Golgi carrier vesicles.
(A) Immunogold labeling of nascent carrier vesicles isolated from HT-29
5M12 cells. Galectin-4 (arrowhead) was labeled with 18-nm gold parti-
cles and DPP-IV (arrow) by 12-nm gold. Bars, 156 nm. In the vesicle prep-
aration, 30% of the vesicles were labeled with the anti–DPP-IV antibody.
20% of these DPP-IV–positive vesicles were also labeled with galectin-4.
(B) Western blotting of galectin-4 in carrier vesicles. Trypsin digestion of
galectin-4 in untreated or Triton X-100–treated carrier vesicles is shown.
(C) Detergent extractability of galectin-4, DPP-IV, and annexins XIIIb and
XIIIa in carrier vesicles from HT-29 5M12 cells. Detergent extracts, i.e.,
Triton X-100 soluble (S), insoluble at 4 C but soluble at 37 C (P1), and
insoluble at 37 C (P2), were analyzed by Western blotting.
Figure 4. Galectin-4 is no longer bound to sulfatides under GalNAc -O-bn
treatment. (A) Co-immunoprecipitation of galectin-4 complexes and HPTLC
analysis of glycolipid ligands. Co-immunoprecipitation was performed from
the same quantity of control and GalNAc -O-bn–treated (14 d and 18 h)
cells. Plates were iodine stained and scanned. The material migrating as
two bands of galactosylceramides (Cer and Cer*) and the trailing corre-
sponding to sulfatides (Sulf and Sulf*) were recovered from the HPTLC plate,
submitted to acid-catalyzed methanolysis and analyzed by GC-MS. Cer,
sphinganine and nonhydroxylated fatty acids; Cer*, sphinganine and
2-hydroxylated fatty acids; Sulf and Sulf*, sphingosine, sphinganine,
phytosphingosine and 6-hydroxy-sphingosine, and 2-hydroxylated fatty ac-
ids from 16 to 28 carbon atoms. (B) Overlay experiments on the four frac-
tions corresponding to the galactosylceramides and sulfatides purified from
human sciatic nerve. Fractions were identified by their eluting methanol per-
cent. Their glycosphingolipids were visualized by orcinol staining and ana-
lyzed for binding to the NH2-terminal CRD and the COOH-terminal CRD of
galectin-4. Control without lectin is presented. arrows show the glycolipids
which bind the NH2-terminal or COOH-terminal domain of galectin-4.GALECTIN-4 AND SULFATIDES IN APICAL TARGETING • DELACOUR ET AL. 497
only present in the DRM fraction detergent insoluble at 37 C
in control cells.
Inhibition of galectin-4 expression 
abrogates apical targeting
To analyze whether galectin-4 had a role in the delivery of api-
cal proteins, we depleted galectin-4 expression in HT-29 5M12
cells by RNA interference (RNAi). Galectin-4 RNAi constructs
and controls are described in Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200407073/DC1.
The level of galectin-4 mRNA depletion was analyzed by
quantitative RT-PCR and Western blotting. The galectin-4 mRNA
was reduced by 80% in the galectin-4-knockdown (KD) cell
population and correlated well with the observed strong reduc-
tion ( 80%) of the galectin-4 protein levels (Fig. 6 A).
We then analyzed the cellular localization of DPP-IV and
two other apical markers, CEA, a glycosylphosphatidylinositol-
anchored protein, and mucin (MUC1), a transmembrane protein,
in the galectin-4-KD cells. In addition, localization of a basolat-
eral marker, E-cadherin, was also studied. In the galectin-4-KD
cells, the amount of DPP-IV, CEA, and MUC1 delivered to the
apical membrane was significantly decreased (Fig. 6 B). Never-
theless, we did not observe mistargeting of DPP-IV, CEA, and
MUC1 to the basolateral membrane upon galectin-4 depletion.
Instead, we saw intracellular accumulation of these glycopro-
teins (Fig. 6 B). Costaining experiments with different organel-
lar markers in galectin-4-KD cells showed partial colocalization
of the cargo with lysosome-associated membrane protein 2 (not
depicted). E-Cadherin localization was not altered in galectin-4-
KD cells (Fig. 6 B). These results indicated that galectin-4 is re-
quired for efficient apical delivery of glycoproteins.
Figure 5. Sulfatides are found in DRMs which are detergent insoluble at 37 C
DRMs were isolated from a total membrane fraction of control and GalNAc -
O-bn–treated (14 d) cells. DRMs were further warmed at 37 C and both the
soluble and insoluble material were collected and examined by HPTLC.
To determine whether galectin-4 depletion affected the or-
ganization of DRMs in HT-29 5M12 cells, we tested the deter-
gent insolubility at 4 and 37 C of glycoproteins at the apical
membrane on living cells. After Triton X-100 treatment of con-
trol cells at 37 C, apical staining of CEA and MUC1 and to some
extent DPP-IV was still seen. In galectin-4-KD cells, CEA,
MUC1, and DPP-IV were no longer detected after Triton X-100
extraction at 37 C (Fig. 7). We also examined the surface deliv-
ery of tsO45 VSVG, using basolateral and apical versions of this
protein. The apical delivery was inhibited in the galectin-4-KD
cells, whereas the basolateral VSV-G protein was transported
normally to the basolateral membrane (Fig. S3, available at
http://www.jcb.org/cgi/content/full/jcb.200407073/DC1).
Inhibition of galectin-4 expression 
decreases apical delivery of newly 
synthesized DPP-IV
To evaluate the impact of galectin-4 depletion on membrane traf-
ficking to the apical or basolateral surfaces, the surface delivery
of DPP-IV was studied using cell surface biotinylation. Chase
times (4 and 6 h) were selected according to a previous study of
the raft association of DPP-IV along its biosynthetic pathway in
this cell type (Delacour et al., 2003). DPP-IV became detergent
insoluble after 4 h. At this time, the maturation of the protein
precursor into the mature glycosylated form was nearly complete
and only the mature form was detergent insoluble. In galectin-4-
KD cells, we observed a fourfold inhibition of DPP-IV delivery
to the apical membrane (Fig. 8). Significant missorting of DPP-
IV to the basolateral surface was not observed.
Discussion
Previous studies have shown that GalNAc -O-bn inhibits the
delivery of several apical proteins in HT-29 cells (Delacour et
al., 2003). Because this inhibitor interferes with glycosylation it
was appealing to assume that a lectin-based sorting mechanism
was the basis for the inhibition. This paper demonstrates that
Figure 6. KD of galectin-4 expression in HT-29 5M12 cells induces mis-
targeting of apical proteins. (A) Western blot analysis of galectin-4 in
empty-RVH-1-virus–infected cells or galectin-4-KD cells. (B) Confocal mi-
croscopy with antibodies directed against apical (MUC1, CEA, DPP-IV)
and basolateral (E-cadherin) proteins, on empty-RVH-1-virus–infected cells
or galectin-4 KD cells. xz sections are shown.JCB • VOLUME 169 • NUMBER 3 • 2005 498
this could indeed be the case. We identified a lectin, galectin-4,
as the main effector of GalNAc -O-bn–mediated effects. This
was based on several findings. First, galectin-4 is apically se-
creted in HT-29 cells. Second, it is a major constituent of
DRMs in enterocytes and in HT-29 cells and could thus be part
of a lectin-based raft clustering mechanism of apical delivery.
Third, GalNAc -O-bn treatment dramatically decreased the ga-
lectin-4 levels in DRMs. Fourth, the inhibitor also seemed to
block the apical secretion of galectin-4. Finally and most im-
portantly, silencing of galectin-4 expression using RNAi inhib-
ited apical transport in the same way as previously shown to oc-
cur by GalNAc -O-bn treatment in HT-29 cells. This is the first
direct demonstration for a role of a lectin in apical transport.
Galectin-4 belongs to the galectin family of lectins, cur-
rently constituted of 15 individual members (Dunphy et al.,
2002; Gray et al., 2004; Leffler et al., 2004). Galectin-4 is mostly
expressed in the gastrointestinal tract of mammals. The HT-29
cells used in this study are derived from a colon adenocarci-
noma. Galectin-4 is a monomer that contains two carbohydrate
binding sites connected by a linker peptide (Oda et al., 1993).
Galectin-4 has been shown to bind with high affinity to O-linked
sulfoglycans (Ideo et al., 2002). The galectins function to form
clusters, arrays or lattices through multivalent protein–carbohy-
drate interactions. These complexes can be a heterogeneous mix-
ture of glycoprotein ligands but remarkably galectins can also
selectively cross-link single glycoprotein species to form lectin-
carbohydrate lattices (Fred Brewer, 2002). Galectins have been
proposed to exert a multitude of functions, which is understand-
able considering that protein cross-linking plays an important
role in cell signaling and membrane trafficking (Fred Brewer,
2002). Galectin-4 has been studied extensively in enterocytes by
Danielsen and coworkers (Danielsen and van Deurs, 1997; Brac-
cia et al., 2003). They have shown that galectin-4 forms what
they call “super rafts” on the apical cell surface and in underly-
ing structures such as deep apical tubules and subapical en-
docytic compartments (Braccia et al., 2003). These “super rafts”
have the unusual property of being partially insoluble after
Triton X-100 extraction at 37 C. One surprising property of ga-
lectins in the context of lectin-based sorting to the apical surface
is the fact that these proteins do not possess signal peptides and
do not use the normal secretory pathway over the Golgi complex
to the cell surface (Hughes, 1999; Nickel, 2003). Instead, galec-
tins accumulate in the cytosol and become externalized by an un-
known mechanism. Where externalization occurs is also not
known. This could take place at the plasma membrane or across
cytoplasmic membrane organelles. Endosomes have been pro-
posed but also translocation across the plasma membrane has
been implicated (Hughes, 1999; Nickel, 2003).
We observed that GalNAc -O-bn inhibited translocation
of galectin-4 to the extracellular side of the apical plasma
membrane. By confocal microscopy we could demonstrate that
galectin-4 was normally localized throughout the cytosol and
accumulated in the subapical region of the HT-29 cells. Immu-
nostaining of unpermeabilized cells showed that galectin-4 was
bound to the extracellular side of the apical membrane. After
GalNAc -O-bn treatment staining of galectin-4 disappeared
from the apical surface and the subapical organelles. This was
Figure 7. Apical glycoproteins are no longer associated with DRMs in
galectin-4-KD HT-29 5M12 cells. Confocal microscopy with antibodies
directed against MUC1, CEA, and DPP-IV, on empty-RVH-1-virus–infected
cells or galectin-4-KD cells, after cell treatment with Triton X-100 at 4 C or
37 C. xz sections were shown.
Figure 8. Apical and basolateral delivery of DPP-IV in control and galectin-
4-KD cells. (A) Cells were pulse labeled for 30 min, and newly synthesized
proteins were chased for 4 or 6 h and biotinylated from the apical or baso-
lateral side. Aliquots from the immunoprecipitations (total) and streptavidin
precipitations (cell surface) are shown. Ap, apical; Bl, basolateral.  , DDP-
IV precursor;  , mature DPP-IV. (B) Apical and total DPP-IV signals were
quantitated in control and in galectin-4-KD cells. The apical to total ratio in
control cells was set to 100% and apical transport efficiency in galectin-
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also shown by fractionation experiments where galectin-4 was
membrane-bound in control cells but became soluble after in-
hibitor treatment. How translocation of galectin-4 to the apical
side is effected is not known. But because GalNAc -O-bn
treatment seemed to inhibit the process one could speculate
that galectin ligands have to be present on the extracytoplasmic
side of the translocation pore for transport across the mem-
brane to occur. Several studies have analyzed which glycosyla-
tion processes GalNAc -O-bn inhibits (Huang et al., 1992;
Byrd et al., 1995; Delannoy et al., 1996; Huet et al., 1998). This
seems to differ with cell type. In HT-29 cells GalNAc -O-bn is
converted into benzyldisaccharide Gal 1-3 GalNAc -O-bn,
which acts as a competitive inhibitor of CMP-NeuAc: Gal 1-
3GalNAc  2,3-sialyltransferase (ST3Gal I), which is involved
in the terminal elongation of O-linked glycans (Delannoy et al.,
1996; Huet et al., 1998). However, other metabolites of the in-
hibitor were also formed, inhibiting other glycosylation en-
zymes (Zanetta et al., 2000). During this work we came up with
a surprise. The major ligands of galectin-4 were found to be
glycosphingolipids. Immunoprecipitation with anti–galectin-4
antibodies in a Triton X-100 and NP-40 mix at RT brought
down galactosylceramides and sulfatides particularly enriched
in long chain 2-hydroxylated fatty acids (50% of 2-hydroxylated;
24:0). The immunoprecipitates surprisingly contained few gly-
coproteins (unpublished data). By overlay assays we could
confirm that recombinant NH2- and COOH-terminal domains
of galectin-4 bound preferentially to sulfatides substituted by
2-hydroxylated fatty acids and to a lesser extent to galactosyl-
ceramides similarly substituted. The 2-hydroxyl group of the
long-chain fatty acids of galactosyl-ceramides and sulfatides is
involved in the specific binding of galectin-4 to these com-
pounds by modifying the conformation of these glycolipids as
already observed by Iida-Tanaka and Ishizuka (2000).
GalNAc -O-bn decreased the level of galactosylcer-
amides and sulfatides. The inhibition of the synthesis of these
glycosphingolipids is not surprising because the UDP-Gal
required for galactosylceramide and sulfatide synthesis is
mobilized by the inhibitor to produce different metabolites of
GalNAc -O-bn (Zanetta et al., 2000). From these results we
conclude that despite its ability to interfere with O-glycosyla-
tion of glycoproteins, GalNAc -O-bn exerts its inhibitory ef-
fect on apical transport mainly by inhibiting the synthesis of
galactosylceramides and sulfatides and by blocking galectin-4
secretion. Most importantly, our data based on RNA silencing
also demonstrate that galectin-4 directly participates in regulat-
ing apical transport. Previously, we have demonstrated that
proteins assumed to be part of the apical delivery mechanism,
syntaxin 3 and annexin XIIIb, also accumulated intracellularly
after inhibitor treatment (Delacour et al., 2003). Similarly, an-
nexin XIIIb was mislocalized in galectin-4–depleted cells
(unpublished data). Thus, both apical cargo and apical machin-
ery seem to depend on galectin-4 function. Galectin-4 could
cross-link glycolipids to form raft platforms for apical sorting.
Another common feature in GalNAc -O-bn–treated and in ga-
lectin-4-KD cells is the lack of missorting of the apical cargo to
the basolateral plasma membrane. This contrasts a number of
earlier reports where inhibition of apical pathway led to mea-
surable missorting to the basolateral pathway (Scheiffele et al.,
1995; Keller and Simons, 1998). The level at which the apical
pathway is affected may play a role. For example, a block at the
level of TGN might still allow misloading of apical proteins for
basolateral delivery but the fate of apical cargo might be differ-
ent if the inhibition is exerted at a later step in the pathway.
Therefore, an important issue that needs to be clarified is where
does galectin-4 enter the biosynthetic pathway. We did observe
galectin-4 in membrane vesicles derived from perforated HT-29
cells. Protease treatment demonstrated that galectin-4 was in
the lumen of these vesicles that also labeled with antibodies
against DPP-IV in immunoelectron microscopy. However, we
do not know exactly where these vesicles derive from.
The route for apical delivery could involve direct deliv-
ery from the TGN but the transcytosis route over the basolat-
eral membrane could also be used (Mostov et al., 2003; Nelson,
2003). Moreover, apical recycling endosomes have been impli-
cated in apical traffic. Nevertheless, we assume that galectin-4
binding to sulfatides and galactosylceramides implicate lipid
rafts in the apical delivery process. By binding to these raft
constituents galectin-4 would cross-link rafts to form raft clus-
ters, postulated to build up the membrane microdomains that
bud off to generate transport carriers (Schuck and Simons,
2004). Because raft partitioning alone is not a sufficient criteria
securing for apical delivery one would have to assume that also
other scaffolding mechanisms (potentially also including direct
lectin sorting of N- and O-glycosylated proteins) participate to
ensure specific apical delivery. Galectin-4 could recycle from
the apical membrane raft bound to facilitate raft clustering dur-
ing biosynthetic transport. Perhaps we have to envisage apical
sorting as a maturation process where the biosynthetic mem-
brane carriers meet with endocytic carriers bringing back the
machinery from the apical transport that will be required for
proper apical delivery. We have perhaps been too strict in our
attempts to define stations in an extremely dynamic network of
membrane trafficking. Future work will have to define how this
post-Golgi circuit operates and what path apical cargo takes
and where it meets with recycling machinery.
Materials and methods
Materials
Recombinant rat galectin-4 CRD domains (C-G4-GST or N-G4-GST using
pGEX-2T expression vectors; provided by K. Wasano, Kyushu University,
Fukuoka, Japan) were prepared as previously described (Wasano and
Hirakawa, 1999; Wu et al., 2002).
Antibodies
For Western blotting experiments, pAbs against porcine galectin-4 and
against human annexin XIII (Intestinal Specific Antigen; Wice and Gordon,
1992) and rat mAb against human DPP-IV (4H3) were gifts from E.M.
Danielsen (University of Copenhagen, Denmark), J. Gordon (Washington
University School of Medicine, St. Louis, MO), and D. Massey (Gorvel et al.,
1991), respectively. For morphological and co-immunoprecipitation experi-
ments, a pAb against human galectin-4 was used (raised as described previ-
ously [Nagy et al., 2003] and checked for lack of cross-reactivity against
other members of the galectin family [i.e., galectins-1, -2, -3, -5, -7, and -8]),
and an mAb against human DPP-IV (HBB 3/775/42; HP Hauri, Biocenter of
the University of Basel). Mouse mAbs against MUC1 (214D4), CEA (517),
and LAMP2 (AC17) and ST3Gal I (4B10) were gifts from J. Hilkens (The
Netherlands Cancer Institute, Amsterdam, Netherlands), A. Le Bivic (IBDM,
Marseille, France) and U. Mandel (School of Dentistry, Copenhagen, Den-JCB • VOLUME 169 • NUMBER 3 • 2005 500
mark), respectively. Mouse mAbs against human DPP-IV (M-A261) and hu-
man E-cadherin (HECD-1) were purchased from BD Biosciences and Takara.
Rabbit pAbs against GST-fusion proteins and calnexin were obtained from
Upstate Biotechnology and Santa Cruz Biotechnology, Inc.
Cell culture
HT-29 clone 5M12 cells were cultured as previously described (Delacour et
al., 2003). GalNAc -O-bn was used at the concentration of 2 mM for 10 d.
Isolation and characterization of DRMs
DRMs were isolated from a total membrane fraction after treatment with
1% Triton X-100 at 4 C (Fiedler et al.,1993).
Vesicle isolation from perforated cells
TGN-derived vesicles were isolated according to the procedure described
by Wandinger-Ness et al. (1990). The absence of ER contamination in the
vesicle preparation was checked by Western blotting with an antibody
against calnexin (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200407073/DC1).
Single and double labellings were performed using rabbit anti–
galectin-4 antibody and mouse anti–DPP-IV antibody (Scheiffele et al., 1998).
Trypsinization was performed with trypsin (0.1  g/ml) for 30 min at 37 C.
Detergent extractability was analyzed by sequential detergent extraction at
4 C and 37 C according to the procedure of Braccia et al. (2003).
Proteomic analysis
2-D gels and MALDI-TOF mass spectrometry analyses were performed as
previously described (Delacour et al., 2003) and silver-stained (Gharah-
daghi et al., 1999).
Lipid extraction and analysis
Lipids were analyzed by HPTLC according to Vitiello and Zanetta (1978)
for neutral lipids, and to Zanetta et al. (1980) for gangliosides and then
by GC/MS as heptafluorobutyrate derivates (Zanetta et al., 1999; Pons et
al., 2000, 2002). Glycolipids were isolated from human sciatic nerve
(Zanetta et al., 1999; Pons et al., 2002).
Separation of cytosol and membranes by saponin treatment
Cells were incubated twice for 30 min at 4 C in PBS containing 2 mg/ml
saponin, 5 mM EDTA, and protease inhibitors. Supernatants were col-
lected and cells were then lysed in warm RIPA buffer (0.1 M Tris-HCl, pH
8.0, 1 M NaCl, 10 mM EDTA, 1% vol/vol Triton X-100, 5% wt/vol so-
dium desoxycholate, 1% vol/vol SDS, protease inhibitors).
Confocal microscopy
Confocal microscopy was performed according to Gouyer et al. (2001)
with pAb anti–galectin-4 (1/50), mAbs anti–DPP-IV (1/100), anti-MUC1
(1/3), anti-CEA (1/500), anti–E-cadherin (1/500), anti–lysosome-asso-
ciated membrane protein 2 (1/500), and anti-ST3Gal I (1/4) using
a DMIRBE microscope (model TCS-NT; Leica) with a 63  1.32 Plan-
Apochromat oil-immersion objective lens. Acquisition was performed us-
ing Power Scan software (Leica) and processed with Adobe Photoshop 5.0.
For trypsinization on living cells, the cells were treated with 0.1
 g/ml trypsin for 10 min at 4 C. For detergent extraction on living cells,
the cells were incubated for 2 min in 10 mM Hepes, pH 7.4, 1 mM
CaCl2, 1% Triton X-100, at 4 or 37 C.
Co-immunoprecipitation
Cells were lysed in a nondenaturing buffer (25 mM Tris-HCl, pH 7.5, 1
mM EDTA, 1 mM EGTA, 100 mM NaCl, 1% Triton X-100, 0.5% NP-40,
and protease inhibitors) at RT. Immunoprecipitation was carried out with
anti–galectin-4 antibody and magnetic beads.
Western blot analysis
The samples were processed as previously described (Gouyer et al., 2001).
Protein-lipid overlay assay
Galactosyl-ceramides and sulfatides from human sciatic nerve were sepa-
rated by chromatography on aluminium-backed silica gel thin layer. Binding
of galectin-4 domains was studied as described previously (Thomas et al.,
2001) in the presence of 0.3% periodate-treated BSA (Glass et al., 1981).
Inhibition of galectin-4 gene expression by retroviral-mediated RNAi
Galectin-4-KD HT-29 5M12 cells were generated by using a retrovirus-
mediated RNAi system as described previously (Schuck et al., 2004).
In brief, oligonucleotides encoding shRNAs directed against galectin-4
mRNA were designed according to recommendations described in Schuck
et al. (2004). The RNAi hairpin was designed to target human galectin-4
sequence 508–528:GGACATTGCCATCAACAGCTG. 0.4    10
6 cells
were seeded into a well of 6-well plate. On the next day, cells were in-
fected with either a control virus (without a hairpin insert) or a Gal-4-KD-
virus in the presence of 8  g/ml polybrene (hexadimethrine bromide;
Fluka). Cells were incubated at 37 C overnight and infection was re-
peated twice with a fresh batch of virus. 1 d after the last infection, trans-
duced cells were selected in the presence of 4  g/ml puromycin for 3 d.
1 wk after selection, the KD efficiency was analyzed by quantitative RT-
PCR and Western blotting.
Pulse-chase and transport assays
Cells were grown on Transwells (Costar Data Packaging) until day 10 and
processed for radiolabeling and cell surface biotinylation (Le Bivic et al.,
1989). Quantitation was performed with Claravision.
Online supplemental material
Fig. S1 shows NMR spectroscopy analysis of the galectin-4 ligands, i.e.,
sulfatide and galactosylceramide. Fig. S2 shows the three galectin-4 RNAi
constructs tested: effect on galectin-4 expression and MUC1 localization.
Fig. S3 shows the biosynthetic transport of basolateral and apical variants
of ts045 VSV-G-GFP-fusion proteins in control and galectin-4 KD cells. Fig.
S4 shows the absence of ER contaminations in the post-Golgi vesicle prep-
arations of HT-29 5M12 cells. Further comments on the data can be found
in the legends. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200407073/DC1.
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